drugset / Trial / NCT04090190

Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics

NCT04090190

NaSingle-groupOpen-labelTreatment

Summary

Urinary incontinence (UI) is a very common condition affecting women of all ages. The objective of this pilot study is to better understand the urinary microbiome and associated inflammatory markers in blood and urine in women with urgency UI. The study will assess how inflammation may affect response to standard of care anticholinergic medication treatment for urgency urinary incontinence.

Timeline

Start
2019-10-30
Primary completion
2021-05-30
Completion
2021-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fesoterodine Other / unclassified
Subject Oxybutynin Small molecule
Subject Solifenacin Small molecule
Subject Tolterodine Small molecule
Subject Trospium Small molecule

Indications